(Solved): the enzyme dihydrofolae reductase is required for DNA synthesis and as such is an attractive drug ta ...

the enzyme dihydrofolae reductase is required for DNA synthesis and as such is an attractive drug target in cancer therapy. The drug methotrexate competes with the substrate DHF for binding to the enzyme. identify thehydrogenbond acceptor and donor groups in MTX and DHF